India Proposes Flexible Factory Rules for Medicinal Gases and Gelatin Capsules

by admin
India Proposes Flexible Factory Rules for Medicinal Gases and Gelatin Capsules

India’s Health Ministry proposed letting licensing officials relax factory rules for medicinal gases, gelatin capsules and disinfectants, with 30 days for comments.

India’s Health Ministry has proposed letting drug licensing officials relax factory rules for medicinal gases, empty gelatin capsules and disinfectant fluids. The public has 30 days from the draft’s release to send objections before the government considers it.

The Ministry of Health and Family Welfare published the draft as Gazette Notification G.S.R. 985(E), dated 6 November 20261. It would amend the Drugs Rules, 1945, so that exemptions these three product types had under the old Schedule M rules carry on under the revised version1. The draft rules will take effect on the date of their final publication in the Official Gazette2.

At a glanceDetails
What was publishedDraft amendment to the Drugs Rules, 1945 (G.S.R. 985(E))
Published on6 November 2026 (notification date)
Who can comment / Who must complyMakers of medicinal gases, empty gelatin capsules and disinfectant fluids, and the public
Feedback deadline / Effective date30 days after copies of the gazette reach the public
Final rules / Next milestoneFinal publication in the Official Gazette, when the rules take effect

What is Schedule M, and why does it matter?

Schedule M is the part of India’s Drugs Rules that sets good manufacturing practice, the basic standards a medicine factory must meet. The government issued a revised Schedule M through G.S.R. 922(E), dated 28 December 20231. The revised rules set out requirements for factory space and equipment.

Stakeholders then told the ministry that certain revised provisions did not fit some products1. The products were medicinal gases, empty gelatin capsules and disinfectant fluids. Their makers said the rules did not match how these goods are produced.

What the expert board recommended

The Drugs Technical Advisory Board (DTAB), an expert panel on drug rules, discussed the issue at its 93rd meeting on 16 February 20261. The board found that some revised requirements may not be relevant to how these three product types are made1.

How the proposal developed

28 Dec 2023 Revised Schedule M issued
16 Feb 2026 DTAB backs old exemptions
6 Nov 2026 Draft notification dated
19 Nov 2026 Ministry announces proposal

It recommended keeping the exemptions these products had before Schedule M was revised1. The draft notification states that the government is acting after consulting the board2.

What the draft rules change

The draft adds a short note at the end of Part XIII of Schedule M2. The note says the schedule does not set specific space and equipment requirements for medicinal gases, empty gelatin capsules and disinfectant fluids2.

The draft at a glance

ProvisionWhat the draft says
Products coveredMedicinal gases, empty gelatin capsules, disinfectant fluids
Who decidesLicensing Authority or Central Licence Approving Authority
Power grantedRelax or alter Schedule M requirements case by case
Takes effectOn final publication in the Official Gazette

Licensing officials gain the power to adjust the rules for these products case by case. The officials named are the Licensing Authority or the Central Licence Approving Authority, depending on the case2.

AreaWhat the draft provides
Products coveredMedicinal gases, empty gelatin capsules, disinfectant fluids2
Who decidesLicensing Authority or Central Licence Approving Authority2
What they may doRelax or alter Schedule M requirements in a particular case2
Basis for a decisionNature of the products and extent of manufacturing operations2
Paper trailReasons must be recorded in writing2

How case-by-case approval would work

An official may relax or change a requirement only if the circumstances of a particular case make it necessary2. The official must record the reasons in writing2.

From review to approval

Official reviews the case Nature of products and operations
Reasons recorded in writing Needed to relax or alter rules
Manufacturer makes changes As the official directs
Manufacture approved After changes are made

The official can then direct the manufacturer to make the needed changes. Once the changes are made, the official can approve manufacture of the product2. The ministry said the change lets licensing officials make product-specific decisions based on scientific and practical considerations1.

Does this weaken quality standards?

The ministry said the proposal does not dilute quality, safety or regulatory oversight standards1. It described the change as a practical, product-specific approach that keeps manufacturers bound by the quality rules that apply to them1.

The draft does not remove these products from Schedule M. It lets officials adjust space and equipment rules where they do not fit a product’s manufacturing process.

How to send comments

The gazette issue carrying the draft is dated 12 November 20262. The government will consider the draft once 30 days have passed from the date copies of that gazette are made available to the public2. It will consider objections and suggestions from any person received within that period2.

Comments go to the Under Secretary (Drugs), Ministry of Health and Family Welfare, Kartavya Bhawan-1, New Delhi 1100111. They can also be emailed to drugsdiv-mohfw@gov.in2.

Key dateWhat happens
28 December 2023Revised Schedule M issued (G.S.R. 922(E))1
16 February 2026DTAB recommends keeping the old exemptions1
6 November 2026Draft notification G.S.R. 985(E) dated2
12 November 2026Gazette issue carrying the draft2
19 November 2026Ministry announces the proposal1

Key terms in plain words

TermMeaning
Drugs Rules, 1945India’s main rules for making, licensing and selling medicines
Schedule MThe part of those rules setting factory standards for medicine makers
Good manufacturing practiceBasic standards for clean, controlled and consistent drug production
DTABDrugs Technical Advisory Board, the expert panel that advises the government on drug rules
Licensing AuthorityThe official who grants and oversees drug manufacturing licences

The government will take up the draft once the 30-day comment period ends, and the rules take effect on final gazette publication2.

Sources

  1. ↩ Press Release Page | Press Information Bureau https://www.pib.gov.in/PressReleasePage.aspx?PRID=2338313&reg=3&lang=1
  2. ↩ 278031.pdf https://egazette.gov.in/WriteReadData/2026/278031.pdf

You may also like